Sunbeatables' lessons in skin cancer prevention now available online to teachers across the US
As teachers across the country prepare for a new school year, it is now easier than ever to make sun safety a part of daily lesson plans with free online access to Ray and the Sunbeatables™, A Sun Safety Curriculum.
The digital Sunbeatables™ Program, which was created and developed by behavioral science researchers at MD Anderson Cancer Center, features free online components that include teacher training and resources, curriculum...
Study helps predict lung cancer patients’ response to checkpoint blockade therapy
An MD Anderson study may help researchers predict which patients with non-small cell lung cancer will respond to checkpoint blockade therapy...
Tumor-targeting drug shows potential for treating bone cancer
The treatment of osteosarcoma, the most common tumor of bone, is challenging. An MD Anderson study found a drug known as bone metastasis-targeting...
Findings may help doctors ‘customize’ glioblastoma treatment
Patterns in how genes express themselves may help doctors personalize treatment for glioblastoma, the most deadly of brain cancers, according to a new MD Anderson study.
The team, led by Erik Sulman, M.D., Ph.D., associate professor of Radiation Oncology, identified gene expression patterns that differed from surrounding immune cells, demonstrating the effects of chemotherapy and radiation treatments. They further defined tumor-intrinsic...
Identifying an enzyme that keeps ovarian cancer safe from immune attacks
A study of high-grade ovarian cancer has shown the enzyme protein kinase C iota (PRKCI) to be an ovarian oncogene, suggesting PRKCI inhibition...
Symposium to address prevention, detection and treatment of HPV-related throat cancer
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the University...
MD Anderson is again No. 1 in cancer care
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
Together, chemo and proton therapy lengthen survival for late-stage lung cancer patients
For patients with advanced, inoperable stage 3 lung cancer, chemotherapy and a specialized form of radiation treatment known as proton...
MD Anderson is first in Texas to be accredited to train tobacco treatment specialists
Since 2006, MD Anderson’s Tobacco Treatment Program (TTP) has been providing tobacco cessation services to patients and employees seeking...
Metastatic colorectal cancer patients with a certain genetic mutation respond well to immunotherapy
A practice-changing clinical trial conceived and led by MD Anderson investigators showed that metastatic colorectal cancer patients with a...